作者：
Fermín,Sánchez-Guijo [1]
;
Cristina,Avendaño-Solá [2]
;
Lina,Badimón [3]
;
Juan A,Bueren [4]
;
Josep M,Canals [5]
;
Joaquim,Delgadillo [6]
;
Julio,Delgado [7]
;
Cristina,Eguizábal [8]
;
María-Eugenia,Fernández-Santos [9]
;
Damián,García-Olmo [10]
;
Gloria,González-Aseguinolaza [11]
;
Manel,Juan [12]
;
Francisco,Martín [8]
;
Rosario,Mata [13]
;
Nuria,Montserrat [14]
;
Antonio,Pérez-Martínez [15]
;
José A,Pérez-Simón [16]
;
Felipe,Prósper [17]
;
Álvaro,Urbano-Ispizua [18]
;
Agustín G,Zapata [19]
;
Anna,Sureda [20]
;
José M,Moraleda [8]
作者单位：
University of Salamanca, IBSAL-University Hospital of Salamanca, Salamanca, Spain. ferminsg@usal.es.
[1]
Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.
[2]
Department of Molecular Pathology and Therapeutics, IR -Hospital de la Santa Creu i Sant Pau, IIBSantPau, CiberCV, Barcelona, Spain.
[3]
Biomedical Innovation Unit, CIEMAT, CIBER Rare Diseases and IIS Fundación Jiménez Díaz, Madrid, Spain.
[4]
Creatio - Production and Validation Center of Advanced Therapies; and Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
[5]
August Pi i Sunyer Biomedical Research Institute (FRCB-IDIBAPS), Barcelona, Spain.
[6]
Banc de Sang i Teixits, Barcelona, Spain.
[7]
Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
[8]
Cell Therapy, Stem Cells and Tissues Group, Basque Center for Blood Transfusion and Human Tissues, Biocruces Bizkaia Health Research Institute, Galdakao, Spain.
[9]
ATMPs Production Unit. IiS-Gregorio Marañón Health (IiSGM), Gregorio Marañón General University Hospital, Madrid, Spain.
[10]
"Fundación Jiménez Díaz" University Hospital. Universidad Autónoma de Madrid, Madrid, Spain.
[11]
Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Programa de Terapia Génica y Regulación de la expresión Génica, Pamplona, Spain.
[12]
Gene & Cell Therapy Group. GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
[13]
Dpt. de Bioquimica y Biologia Molecular III e Inmunologia. Facultad de Medicina, Universidad de Granada, Granada, Spain.
[14]
Coordination Unit of the Andalusian Network for the Design and Translation of Advanced Therapies, Seville, Spain.
[15]
Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
[16]
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
[17]
Universidad Autónoma de Madrid, Institute for Health Research (IdiPAZ), University Hospital La Paz, Madrid, Spain.
[18]
Department of Hematology, University Hospital Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBIS)/CISC, Universidad de Sevilla, Sevilla, Spain.
[19]
Servicio de Hematologia y Terapia Celular, Clinica Universidad de Navarra, IdISNA, CIBERONC and CCUN, Pamplona, Spain.
[20]
Faculty of Biology. Dept of Cell Biology, Complutense University, Madrid, Spain.
[21]
Departament d'hematologia, Institut Català d'Oncologia-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain.
[22]
University of Murcia, IMIB-University Hospital Virgen de la Arrixaca, Murcia, Spain.
[23]
DOI
10.1038/s41409-023-01962-0
PMID
36966215
发布时间
2023-06-11
换一批
换一批
